 | • レポートコード：D0GIR-00926 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インフルエンザ用迅速診断検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザ用迅速診断検査の種類別市場規模（デジタル迅速インフルエンザ診断検査、従来迅速インフルエンザ診断検査）、用途別市場規模（ポイントオブケア検査、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbot、Princeton BioMeditech Corporation、Roche、BD、Analytik Jena、Quidel、Sekisui Diagnostics、Meridian Bioscience、Thermo Fisher Scientific、BioMerieux、Response Biomedical、SA Scientific ・地域別グローバル市場分析 2015年-2020年 ・インフルエンザ用迅速診断検査の北米市場（アメリカ、カナダ、メキシコ） ・インフルエンザ用迅速診断検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インフルエンザ用迅速診断検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インフルエンザ用迅速診断検査の南米市場（ブラジル、アルゼンチン） ・インフルエンザ用迅速診断検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：デジタル迅速インフルエンザ診断検査、従来迅速インフルエンザ診断検査 ・用途別分析：ポイントオブケア検査、病院、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Rapid Diagnostic Testing for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Rapid Diagnostic Testing for Influenza sales will be xx in 2020 from Rapid Diagnostic Testing for Influenza million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Rapid Diagnostic Testing for Influenza market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Rapid Diagnostic Testing for Influenza industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Rapid Diagnostic Testing for Influenza and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Rapid Diagnostic Testing for Influenza market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rapid Diagnostic Testing for Influenza market has been segmented into:
Digital Rapid Influenza Diagnostic Test
Conventional Rapid Influenza Diagnostic Test
By Application, Rapid Diagnostic Testing for Influenza has been segmented into:
Point-of-care Testing
Hospitals
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rapid Diagnostic Testing for Influenza market presented in the report. This section sheds light on the sales growth of different regional and country-level Rapid Diagnostic Testing for Influenza markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rapid Diagnostic Testing for Influenza market.
The report offers in-depth assessment of the growth and other aspects of the Rapid Diagnostic Testing for Influenza market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Rapid Diagnostic Testing for Influenza Market Share Analysis
Rapid Diagnostic Testing for Influenza competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rapid Diagnostic Testing for Influenza sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rapid Diagnostic Testing for Influenza sales, revenue and market share for each player covered in this report.
The major players covered in Rapid Diagnostic Testing for Influenza are:
Abbot
Princeton BioMeditech Corporation
Roche
BD
Analytik Jena
Quidel
Sekisui Diagnostics
Meridian Bioscience
Thermo Fisher Scientific
BioMerieux
Response Biomedical
SA Scientific
Among other players domestic and global, Rapid Diagnostic Testing for Influenza market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Rapid Diagnostic Testing for Influenza Market Overview
1.1 Product Overview and Scope of Rapid Diagnostic Testing for Influenza
1.2 Classification of Rapid Diagnostic Testing for Influenza by Type
1.2.1 Global Rapid Diagnostic Testing for Influenza Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type in 2019
1.2.3 Digital Rapid Influenza Diagnostic Test
1.2.4 Conventional Rapid Influenza Diagnostic Test
1.3 Global Rapid Diagnostic Testing for Influenza Market by Application
1.3.1 Overview: Global Rapid Diagnostic Testing for Influenza Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Point-of-care Testing
1.3.3 Hospitals
1.3.4 Others
1.4 Global Rapid Diagnostic Testing for Influenza Market by Regions
1.4.1 Global Rapid Diagnostic Testing for Influenza Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rapid Diagnostic Testing for Influenza (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rapid Diagnostic Testing for Influenza Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rapid Diagnostic Testing for Influenza Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rapid Diagnostic Testing for Influenza Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rapid Diagnostic Testing for Influenza Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rapid Diagnostic Testing for Influenza Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Rapid Diagnostic Testing for Influenza Industry Impact
1.5.1 COVID-19 Potential Implications for the Rapid Diagnostic Testing for Influenza
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Rapid Diagnostic Testing for Influenza
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Abbot
2.1.1 Abbot Details
2.1.2 Abbot Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbot SWOT Analysis
2.1.4 Abbot Product and Services
2.1.5 Abbot Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.2 Princeton BioMeditech Corporation
2.2.1 Princeton BioMeditech Corporation Details
2.2.2 Princeton BioMeditech Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Princeton BioMeditech Corporation SWOT Analysis
2.2.4 Princeton BioMeditech Corporation Product and Services
2.2.5 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BD SWOT Analysis
2.4.4 BD Product and Services
2.4.5 BD Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.5 Analytik Jena
2.5.1 Analytik Jena Details
2.5.2 Analytik Jena Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Analytik Jena SWOT Analysis
2.5.4 Analytik Jena Product and Services
2.5.5 Analytik Jena Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.6 Quidel
2.6.1 Quidel Details
2.6.2 Quidel Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Quidel SWOT Analysis
2.6.4 Quidel Product and Services
2.6.5 Quidel Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sekisui Diagnostics
2.7.1 Sekisui Diagnostics Details
2.7.2 Sekisui Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sekisui Diagnostics SWOT Analysis
2.7.4 Sekisui Diagnostics Product and Services
2.7.5 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.8 Meridian Bioscience
2.8.1 Meridian Bioscience Details
2.8.2 Meridian Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Meridian Bioscience SWOT Analysis
2.8.4 Meridian Bioscience Product and Services
2.8.5 Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific SWOT Analysis
2.9.4 Thermo Fisher Scientific Product and Services
2.9.5 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.10 BioMerieux
2.10.1 BioMerieux Details
2.10.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BioMerieux SWOT Analysis
2.10.4 BioMerieux Product and Services
2.10.5 BioMerieux Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Response Biomedical SWOT Analysis
2.11.4 Response Biomedical Product and Services
2.11.5 Response Biomedical Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
2.12 SA Scientific
2.12.1 SA Scientific Details
2.12.2 SA Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 SA Scientific SWOT Analysis
2.12.4 SA Scientific Product and Services
2.12.5 SA Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rapid Diagnostic Testing for Influenza Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rapid Diagnostic Testing for Influenza Players Market Share
3.2.2 Top 10 Rapid Diagnostic Testing for Influenza Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rapid Diagnostic Testing for Influenza Revenue and Market Share by Regions
4.2 North America Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
4.3 Europe Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
4.5 South America Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
5 North America Rapid Diagnostic Testing for Influenza Revenue by Countries
5.1 North America Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
5.2 USA Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
5.3 Canada Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
5.4 Mexico Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
6 Europe Rapid Diagnostic Testing for Influenza Revenue by Countries
6.1 Europe Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
6.2 Germany Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
6.3 UK Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
6.4 France Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
6.5 Russia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
6.6 Italy Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Countries
7.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
7.2 China Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
7.3 Japan Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
7.4 Korea Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
7.5 India Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
8 South America Rapid Diagnostic Testing for Influenza Revenue by Countries
8.1 South America Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
8.2 Brazil Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
8.3 Argentina Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rapid Diagnostic Testing for Influenza by Countries
9.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
9.3 UAE Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
9.4 Egypt Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
9.5 South Africa Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rapid Diagnostic Testing for Influenza Revenue and Market Share by Type (2015-2020)
10.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Type (2019-2024)
10.3 Digital Rapid Influenza Diagnostic Test Revenue Growth Rate (2015-2025)
10.4 Conventional Rapid Influenza Diagnostic Test Revenue Growth Rate (2015-2025)
11 Global Rapid Diagnostic Testing for Influenza Market Segment by Application
11.1 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2015-2020)
11.2 Rapid Diagnostic Testing for Influenza Market Forecast by Application (2019-2024)
11.3 Point-of-care Testing Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Rapid Diagnostic Testing for Influenza Market Size Forecast (2021-2025)
12.1 Global Rapid Diagnostic Testing for Influenza Market Size Forecast (2021-2025)
12.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Regions (2021-2025)
12.3 North America Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
12.4 Europe Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
12.6 South America Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Rapid Diagnostic Testing for Influenza Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rapid Diagnostic Testing for Influenza by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rapid Diagnostic Testing for Influenza Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rapid Diagnostic Testing for Influenza Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Rapid Diagnostic Testing for Influenza Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbot Corporate Information, Location and Competitors
Table 7. Abbot Rapid Diagnostic Testing for Influenza Major Business
Table 8. Abbot Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 9. Abbot SWOT Analysis
Table 10. Abbot Rapid Diagnostic Testing for Influenza Product and Solutions
Table 11. Abbot Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Princeton BioMeditech Corporation Corporate Information, Location and Competitors
Table 13. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Major Business
Table 14. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2018-2019)
Table 15. Princeton BioMeditech Corporation SWOT Analysis
Table 16. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product and Solutions
Table 17. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Roche Corporate Information, Location and Competitors
Table 19. Roche Rapid Diagnostic Testing for Influenza Major Business
Table 20. Roche Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 21. Roche SWOT Analysis
Table 22. Roche Rapid Diagnostic Testing for Influenza Product and Solutions
Table 23. Roche Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. BD Corporate Information, Location and Competitors
Table 25. BD Rapid Diagnostic Testing for Influenza Major Business
Table 26. BD Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 27. BD SWOT Analysis
Table 28. BD Rapid Diagnostic Testing for Influenza Product and Solutions
Table 29. BD Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Analytik Jena Corporate Information, Location and Competitors
Table 31. Analytik Jena Rapid Diagnostic Testing for Influenza Major Business
Table 32. Analytik Jena Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 33. Analytik Jena SWOT Analysis
Table 34. Analytik Jena Rapid Diagnostic Testing for Influenza Product and Solutions
Table 35. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Quidel Corporate Information, Location and Competitors
Table 37. Quidel Rapid Diagnostic Testing for Influenza Major Business
Table 38. Quidel Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 39. Quidel SWOT Analysis
Table 40. Quidel Rapid Diagnostic Testing for Influenza Product and Solutions
Table 41. Quidel Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Sekisui Diagnostics Corporate Information, Location and Competitors
Table 43. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Major Business
Table 44. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 45. Sekisui Diagnostics SWOT Analysis
Table 46. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product and Solutions
Table 47. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Meridian Bioscience Corporate Information, Location and Competitors
Table 49. Meridian Bioscience Rapid Diagnostic Testing for Influenza Major Business
Table 50. Meridian Bioscience Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 51. Meridian Bioscience SWOT Analysis
Table 52. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product and Solutions
Table 53. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 55. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Major Business
Table 56. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 57. Thermo Fisher Scientific SWOT Analysis
Table 58. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product and Solutions
Table 59. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. BioMerieux Corporate Information, Location and Competitors
Table 61. BioMerieux Rapid Diagnostic Testing for Influenza Major Business
Table 62. BioMerieux Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 63. BioMerieux SWOT Analysis
Table 64. BioMerieux Rapid Diagnostic Testing for Influenza Product and Solutions
Table 65. BioMerieux Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Response Biomedical Corporate Information, Location and Competitors
Table 67. Response Biomedical Rapid Diagnostic Testing for Influenza Major Business
Table 68. Response Biomedical Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 69. Response Biomedical SWOT Analysis
Table 70. Response Biomedical Rapid Diagnostic Testing for Influenza Product and Solutions
Table 71. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. SA Scientific Corporate Information, Location and Competitors
Table 73. SA Scientific Rapid Diagnostic Testing for Influenza Major Business
Table 74. SA Scientific Rapid Diagnostic Testing for Influenza Total Revenue (USD Million) (2017-2018)
Table 75. SA Scientific SWOT Analysis
Table 76. SA Scientific Rapid Diagnostic Testing for Influenza Product and Solutions
Table 77. SA Scientific Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) by Players (2015-2020)
Table 79. Global Rapid Diagnostic Testing for Influenza Revenue Share by Players (2015-2020)
Table 80. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Regions (2015-2020)
Table 82. North America Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
Table 83. North America Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Table 84. Europe Rapid Diagnostic Testing for Influenza Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Rapid Diagnostic Testing for Influenza Revenue by Countries (2015-2020)
Table 87. South America Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Table 90. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) by Type (2015-2020)
Table 91. Global Rapid Diagnostic Testing for Influenza Revenue Share by Type (2015-2020)
Table 92. Global Rapid Diagnostic Testing for Influenza Revenue Forecast by Type (2021-2025)
Table 93. Global Rapid Diagnostic Testing for Influenza Revenue by Application (2015-2020)
Table 94. Global Rapid Diagnostic Testing for Influenza Revenue Share by Application (2015-2020)
Table 95. Global Rapid Diagnostic Testing for Influenza Revenue Forecast by Application (2021-2025)
Table 96. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rapid Diagnostic Testing for Influenza Picture
Figure 2. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type in 2019
Figure 3. Digital Rapid Influenza Diagnostic Test Picture
Figure 4. Conventional Rapid Influenza Diagnostic Test Picture
Figure 5. Rapid Diagnostic Testing for Influenza Revenue Market Share by Application in 2019
Figure 6. Point-of-care Testing Picture
Figure 7. Hospitals Picture
Figure 8. Others Picture
Figure 9. Global Rapid Diagnostic Testing for Influenza Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Rapid Diagnostic Testing for Influenza Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Rapid Diagnostic Testing for Influenza Revenue Market Share in 2019
Figure 18. Global Top 10 Players Rapid Diagnostic Testing for Influenza Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Regions (2015-2020)
Figure 22. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Regions in 2018
Figure 23. North America Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 24. Europe Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 26. South America Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 28. North America Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Figure 29. North America Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries in 2019
Figure 30. USA Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 31. Canada Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 33. Europe Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries in 2019
Figure 35. Germany Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 36. UK Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 37. France Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 38. Russia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 39. Italy Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries in 2019
Figure 42. China Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 43. Japan Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 44. Korea Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 45. India Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 47. South America Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Figure 48. South America Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries in 2019
Figure 49. Brazil Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 54. UAE Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2015-2020)
Figure 57. Global Rapid Diagnostic Testing for Influenza Revenue Share by Type (2015-2020)
Figure 58. Global Rapid Diagnostic Testing for Influenza Revenue Share by Type in 2019
Figure 59. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Type (2021-2025)
Figure 60. Global Digital Rapid Influenza Diagnostic Test Revenue Growth Rate (2015-2020)
Figure 61. Global Conventional Rapid Influenza Diagnostic Test Revenue Growth Rate (2015-2020)
Figure 62. Global Rapid Diagnostic Testing for Influenza Revenue Share by Application (2015-2020)
Figure 63. Global Rapid Diagnostic Testing for Influenza Revenue Share by Application in 2019
Figure 64. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Application (2021-2025)
Figure 65. Global Point-of-care Testing Revenue Growth Rate (2015-2020)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Rapid Diagnostic Testing for Influenza Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Rapid Diagnostic Testing for Influenza Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
Figure 72. Europe Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
Figure 74. South America Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
感染症迅速診断検査キットの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…- 感染症迅速診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 迅速診断テストキットの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Rapid Diagnostic Test Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 迅速医療診断装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Rapid Medical Diagnostic Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 便潜血（FOBT）迅速診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Fecal Occult Blood (FOBT) Rapid Diagnostic Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…